Skip to main content

Table 5 Comparison of positron emission tomography patterns between the Oxford-AstraZeneca and Moderna COVID-19 vaccines and the H1N1 influenza vaccine ([19])

From: Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on 18F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine

Vaccine type

HLN incidence %

HLN SUVmax

DL incidence

DL SUVmax

ChAdOx1

14

3.0 ± 1.3a

10%

2.2 ± 0.9

mRNA-1237

24

3.0 ± 1.3b

8%

1.9 ± 0.6

H1N1

29

2.4 ± 1.1

NAc

2.9 ± 1.2

  1. HLN, hypermetabolic lymphadenopathy; DL, deltoid muscle uptake
  2. a ChAdOx1 vs. H1N1, p = 0.11
  3. b mRNA-1237 vs. H1N1, p = 0.09
  4. c NA: not available
Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us